Core Viewpoint - Guangzhou Kelairedi Medical Equipment Co., Ltd. has completed its IPO counseling report with Galaxy Securities, marking a significant step towards its listing on the Beijing Stock Exchange [2][3] Company Overview - Kelairedi was established in 2000 with a registered capital of 61.8 million yuan, focusing on medical consumables and equipment for oncology radiation and orthopedic rehabilitation, providing comprehensive solutions including R&D, design, production, sales, and technical services [3] - The actual controllers of the company are Zhan Derun and his spouse Li Li, who directly hold 1.60% of the voting rights and indirectly control 63.33% through other entities, totaling 64.93% of the voting rights [3] Management Background - Zhan Derun, aged 65, has a background in chemistry and biochemistry education, with experience in various medical and managerial roles before founding Kelairedi [3] - Li Li, aged 60, has extensive experience in nursing and management within the healthcare sector, currently serving as a director of the company [4] Financial Performance - In 2022, the company reported revenue of 233 million yuan and a net profit of approximately 69.37 million yuan, while in 2023, revenue slightly increased to 238 million yuan but net profit decreased to about 59.92 million yuan, indicating a situation of revenue growth without profit increase [4] - The comprehensive gross profit margins for 2022 and 2023 were 64.63% and 63.26%, respectively [4]
科莱瑞迪由创业板转战北交所IPO，65岁董事长詹德仁曾是卫校化学老师